These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8731932)

  • 1. Immunoregulatory effects of indomethacin on rats with trauma.
    Pan YC; Zhang SX; Ding XZ; Li H
    J Tongji Med Univ; 1995; 15(4):234-7. PubMed ID: 8731932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cimetidine on IL-2 and T suppressor cell function in rats with obstructive jaundice.
    Ding XZ; Li H; Xiong ST; Zhang SX; Lu KZ; Shao JF; Shen GX; Yang J
    J Tongji Med Univ; 1994; 14(2):94-7. PubMed ID: 7966522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced modulation of IL-2 production in experimental murine trypanosomiasis.
    Calabresi A; Perito S; Romani L; Bistoni F
    Int J Immunopharmacol; 1992 Oct; 14(7):1165-73. PubMed ID: 1452401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulatory activity of culture-induced suppressor macrophages.
    Veit BC
    Cell Immunol; 1982 Sep; 72(1):14-27. PubMed ID: 6216958
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of immuno-modulating agents on murine IL-2 production.
    Weng XC; Zhang P; Gong SS; Xiai SW
    Immunol Invest; 1987 Apr; 16(2):79-86. PubMed ID: 2957320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating effects of the synthetic thymic dipeptide pidotimod on the immune system in the aging rat.
    Chiarenza A; Iurato MP; Barbera N; Lempereur L; Cantarella G; Scapagnini U; Bernardini R
    Pharmacol Toxicol; 1994; 74(4-5):262-6. PubMed ID: 8090697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery.
    Faist E; Markewitz A; Fuchs D; Lang S; Zarius S; Schildberg FW; Wachter H; Reichart B
    Ann Surg; 1991 Sep; 214(3):264-73; discussion 274-5. PubMed ID: 1929608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular origins and target cells of immunoregulatory factors in mice with disseminated histoplasmosis.
    Deepe GS; Watson SR; Bullock WE
    J Immunol; 1984 Apr; 132(4):2064-71. PubMed ID: 6230399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarthritic and immunoregulatory activity of spirogermanium.
    DiMartino MJ; Lee JC; Badger AM; Muirhead KA; Mirabelli CK; Hanna N
    J Pharmacol Exp Ther; 1986 Jan; 236(1):103-10. PubMed ID: 2934544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor cells in the peripheral blood and spleen of patients with Hodgkin's disease.
    Minassian AA
    Cancer; 1986 May; 57(9):1756-61. PubMed ID: 2937528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of cytotoxic T-cell generation by natural suppressor cells from mice with GVHD is partially reversed by indomethacin.
    Choi KL; Maier T; Holda JH; Claman HN
    Cell Immunol; 1988 Apr; 112(2):271-8. PubMed ID: 2965616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different mechanisms account for the suppression of interleukin 2 production and the suppression of interleukin 2 receptor expression in Trypanosoma brucei-infected mice.
    Sileghem M; Darji A; Remels L; Hamers R; De Baetselier P
    Eur J Immunol; 1989 Jan; 19(1):119-24. PubMed ID: 2563971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of indomethacin-sensitive suppressor cells by xenogeneic blood transfusion in mice.
    Kubera M; Holán V; Skowron-Cendrzak A; Bubak-Satora M; Stĕdra J; Mazur-Kolecka B
    Folia Biol (Krakow); 1989; 37(1-2):73-82. PubMed ID: 2528480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of interleukin-2 in the age-related impairment of immune function.
    Thoman ML
    J Am Geriatr Soc; 1985 Nov; 33(11):781-7. PubMed ID: 2932499
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppressor cell regulation of cell-mediated immune responses in renal infection in vitro modulation of suppressor cell activity.
    Miller T; Marshall E
    J Clin Invest; 1980 Oct; 66(4):621-8. PubMed ID: 6448267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells.
    Rola-Pleszczynski M; Pouliot C; Turcotte S; Pignol B; Braquet P; Bouvrette L
    J Immunol; 1988 May; 140(10):3547-52. PubMed ID: 2834440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal activation and loss of suppressor T cells in the spontaneously hypertensive rat.
    Ofosu-Appiah W; Ruggiero C
    Cell Immunol; 1992 Nov; 145(1):130-45. PubMed ID: 1423639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha (IL-2) production in patients with major trauma.
    Faist E; Mewes A; Baker CC; Strasser T; Alkan SS; Rieber P; Heberer G
    J Trauma; 1987 Aug; 27(8):837-48. PubMed ID: 2956432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taenia taeniaeformis: inhibition of mitogen induced proliferation and interleukin-2 production in rat splenocytes by larval in vitro product.
    Burger CJ; Rikihisa Y; Lin YC
    Exp Parasitol; 1986 Oct; 62(2):216-22. PubMed ID: 2943603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocyte function during experimental Chagas' disease: production of and response to interleukin 2.
    Harel-Bellan A; Joskowicz M; Fradelizi D; Eisen H
    Eur J Immunol; 1985 May; 15(5):438-42. PubMed ID: 3158531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.